Mitchell Glass - 17 Apr 2025 Form 4 Insider Report for TNF Pharmaceuticals, Inc. (TNFA)

Role
President, CMO, Director
Signature
/s/ Mitchell Glass
Issuer symbol
TNFA
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
4
Filing time
18 Apr 2025, 16:30:12 UTC
Previous filing
16 May 2024
Next filing
06 Oct 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNFA Employee Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 17 Apr 2025 Common Stock 125,000 $0.1832 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options are subject to expiration if the employment of the Reporting Person is terminated.